MedTrace Logo

Metoclopramide Versus Hyoscine Butylbromide in Shortening Duration of First Stage of Labour

NCT05222646 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-02-03

No results posted yet for this study

Summary

BACKGROUND Prolonged labour can lead to increased maternal and neonatal mortality and morbidity. The risk for complications of prolonged labour is more in poor resource settings. Active management of labour has been shown to decrease the occurrence of prolonged labour. Administering antispasmodics during labour could also lead to faster and more effective dilatation of the cervix. As the evidence to support this is still largely anecdotal around the world, there is a need to conduct clinical trials so as to obtain a valid answer.

Conditions

  • Duration of Labour

Interventions

DRUG

Metoclopramide

Will receive single dose of 10mg of Metoclopramide intramuscularly

Sponsors & Collaborators

  • Uwakwe Emmanuel Chijioke

    lead OTHER

Principal Investigators

  • Uwakwe DR Emmanuel Chijioke, PART 1 · Alex Ekwueme Federal University Teaching Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2022-08-03
Completion
2022-08-30

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05222646 on ClinicalTrials.gov